相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
Milad Ashrafizadeh et al.
BIOMEDICINE & PHARMACOTHERAPY (2021)
Designing for a green chemistry future
Julie B. Zimmerman et al.
SCIENCE (2020)
Adverse Events Following Cancer Immunotheraoy: Obstacles and Opportunities
Kristen E. Pauken et al.
TRENDS IN IMMUNOLOGY (2019)
DHA-SBT-1214 Taxoid Nanoemulsion and Anti-PD-L1 Antibody Combination Therapy Enhances Antitumor Efficacy in a Syngeneic Pancreatic Adenocarcinoma Model
Gulzar Ahmed et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer A Randomized Clinical Trial
Gerald Falchook et al.
JAMA ONCOLOGY (2019)
Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer
Santosh Kumar Singh et al.
CANCER LETTERS (2018)
Taxol Analogues Exhibit Differential Effects on Photoaffinity Labeling of β-Tubulin and the Multidrug Resistance Associated P-Glycoprotein
Chia-Ping Huang Yang et al.
JOURNAL OF NATURAL PRODUCTS (2018)
Quest for Efficacious Next-Generation Taxoid Anticancer Agents and Their Tumor-Targeted Delivery
Iwao Ojima et al.
JOURNAL OF NATURAL PRODUCTS (2018)
Substituents at the C3 ' and C3 ' N positions are critical for taxanes to overcome acquired resistance of cancer cells to paclitaxel
Michael Jelinek et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Overcoming multiple drug resistance in cancer using polymeric micelles
Siddharth S. Kesharwani et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness
Beth S. Woods et al.
EUROPEAN UROLOGY ONCOLOGY (2018)
The E factor 25 years on: the rise of green chemistry and sustainability
Roger A. Sheldon
GREEN CHEMISTRY (2017)
被撤回的出版物: SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells (Retracted article. See vol. 63, pg. 104, 2023)
Xiaowei Zheng et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient
Elsa Hansen et al.
PLOS BIOLOGY (2017)
Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response
Lei Jiang et al.
BIOMATERIALS (2015)
Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
Sara M. Tolaney et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
Leisha A. Emens et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances
Ruth Matesanz et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles
Lauren M. Zasadil et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Cabazitaxel: More Than a New Taxane for Metastatic Castrate-Resistant Prostate Cancer?
Alain C. Mita et al.
CLINICAL CANCER RESEARCH (2012)
Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice
Lukas W. Pfannenstiel et al.
CELLULAR IMMUNOLOGY (2010)
Microtubules and resistance to tubulin-binding agents
Maria Kavallaris
NATURE REVIEWS CANCER (2010)
Design, synthesis, and biological evaluation of new-generation taxoids
Iwao Ojima et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Design, synthesis, and bioactivity of simplified paclitaxel analogs based on the T-Taxol bioactive conformation
T Ganesh et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
The seco-taxane IDN5390 is able to target class III β-tubulin and to overcome paclitaxel resistance
C Ferlini et al.
CANCER RESEARCH (2005)
Design, synthesis, and bioactivities of steroid-linked taxol analogues as potential targeted drugs for prostate and breast cancer
CH Liu et al.
JOURNAL OF NATURAL PRODUCTS (2004)
Cytotoxic chemotherapy in advanced non-small cell lung cancer: A review of standard treatment paradigms
MA Socinski
CLINICAL CANCER RESEARCH (2004)
Broad-spectrum modulation of ATP-binding cassette transport proteins by the taxane derivatives ortataxel (IDN-5109, BAY 59-8862) and tRA96023
H Minderman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study
RF Ozols et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Synthesis and biological evaluation of C-3′NH/C-10 and C-2/C-10 modified paclitaxel analogues
E Baloglu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Design and synthesis of a combinatorial chemistry library of 7-acyl, 10-acyl, and 7,10-diacyl analogues of paclitaxel (Taxol) using solid phase synthesis
PG Jagtap et al.
JOURNAL OF NATURAL PRODUCTS (2002)
分享论文
